Edition:
United States

Amgen Inc - Evenity Receives Approval In Japan For Treatment Of Osteoporosis


Tuesday, 8 Jan 2019 04:00pm EST 

Jan 8 (Reuters) - Amgen Inc ::EVENITY(ROMOSOZUMAB) RECEIVES APPROVAL IN JAPAN FOR THE TREATMENT OF OSTEOPOROSIS IN PATIENTS AT HIGH RISK OF FRACTURE.AMGEN INC - EVENITY IN JAPAN IS BEING CO-DEVELOPED THROUGH STRATEGIC ALLIANCE WITH AMGEN ASTELLAS BIOPHARMA.AMGEN INC - JAPANESE MINISTRY OF HEALTH, LABOR AND WELFARE HAS GRANTED A MARKETING AUTHORIZATION FOR EVENITY.